ArticleACS omega2017

Ligand Selectivity between the ADP-Ribosylating Toxins: An Inverse-Docking Study for Multitarget Drug Discovery.

Patricia Saenz-Méndez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.